50 Mg Cyclophosphamide Tablets IP

Name: 50 Mg Cyclophosphamide Tablets IP
Brand: NEETCO BIOPHARMA
Price: 45 INR
Availability: InStock

Price 45 INR/ Strip

Get a Price/Quote

MOQ : 10 Strips

50 Mg Cyclophosphamide Tablets IP Specification

Indication
It is indicated for the treatment of various cancers like lymphoma, leukemia, multiple myeloma, breast cancer, and ovarian cancer, as well as nephrotic syndrome.

Dosage Form
Tablet

Salt Composition
Cyclophosphamide 50 mg

Feature
Potent alkylating anticancer agent, oral administration

Ingredients
Cyclophosphamide, Excipients

Application

Physical Color/Texture
White, round, film-coated tablets

Fermentation Smell
Odorless

Storage Instructions
Store below 25C in a dry place, protect from light and moisture

Shelf Life
24 months

About 50 Mg Cyclophosphamide Tablets IP

Cycloxan 50 Mg Tablets exemplify masterful advancement in cancer treatment, delivered in unassailable blister strips of 10, each reserved for prescription-only use. Formulated with 50 mg of unrivaled Cyclophosphamide per tablet, these top-tier alkylating agents are indicated for oncology applications: the treatment of lymphoma, leukemia, multiple myeloma, breast and ovarian cancer, and nephrotic syndrome. Oral administration ensures ease of use, supported by Indian pharmaceutical expertise. Advance purchase is recommended for streamlined supply. Tablets are odorless, white, round, and film-coated, preserving efficacy in dry, light-protected conditions.

Commercial Uses and Special Features of Cycloxan 50 Mg Tablets

Cycloxan 50 Mg Tablets serve as an essential tool for oncology professionals in the management of various cancers and nephrotic syndrome. Their potent alkylating action, reserved for advanced chemotherapy regimens, demonstrates unrivaled efficacy in suppressing malignant cell growth. The oral dosage form enhances patient convenience and compliance, while the white, film-coated tablet ensures uniformity and easy identification. Used solely under expert medical supervision, these tablets are a top choice among distributors and healthcare institutions for commercial supply.

Delivery Time, Domestic Market, and Supply Ability

Cycloxan 50 Mg Tablets are dispatched via secure goods transport channels, ensuring prompt arrival at healthcare facilities. With robust distribution networks across India, supply ability remains steady to meet commercial demands. The main domestic market encompasses hospitals and oncology centers, where asking price considerations align with bulk procurement needs. Reliable transporter partnerships guarantee minimum delays, safeguarding the integrity and potency of every batch throughout transit and until delivery at the destination.

FAQ's of 50 Mg Cyclophosphamide Tablets IP:

Q: How should Cycloxan 50 Mg Tablets be stored for optimal preservation?

A: Cycloxan 50 Mg Tablets must be stored below 25C in a dry place, protected from light and moisture to maintain their potency throughout the 24-month shelf life.

Q: What conditions are Cycloxan 50 Mg Tablets indicated for?

A: These tablets are indicated for treating various cancers such as lymphoma, leukemia, multiple myeloma, breast cancer, ovarian cancer, and for managing nephrotic syndrome.

Q: When is advance purchase of Cycloxan 50 Mg recommended?

A: Advance purchase is advised for uninterrupted supply during high-demand periods in hospitals, clinics, and for oncology procurement planning.

Q: Where can Cycloxan 50 Mg Tablets be acquired?

A: Cycloxan 50 Mg Tablets are available through licensed distributors, exporters, suppliers, and traders throughout India, supporting domestic and commercial procurement.

Q: What is the process for using Cycloxan 50 Mg Tablets safely?

A: Cycloxan 50 Mg Tablets must be used strictly under medical supervision, as they carry risks such as immunosuppression, bone marrow suppression, and other side effects requiring careful monitoring.

Q: How does Cycloxan 50 Mg benefit cancer treatment?

A: This potent alkylating agent disrupts cancer cell DNA replication, offering effective therapy for various malignancies and improving patient outcomes when included in chemotherapy regimens.

Tell us about your requirement